{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05648591",
            "orgStudyIdInfo": {
                "id": "VP-VYV-683-4101"
            },
            "organization": {
                "fullName": "Vanda Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "Safety and Tolerability of Open-Labeled Iloperidone in Adolescents",
            "officialTitle": "Open-label Safety Study of a 1-year 8 to 24 mg/Day Dose Regimen of Iloperidone (FANAPT\u00ae) in Adolescent Patients With Schizophrenia or Bipolar I Disorder",
            "therapeuticArea": [
                "Mental Health"
            ],
            "study": "safety-and-tolerability-of-open-labeled-iloperidone-in-adolescents"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-12-05",
            "studyFirstSubmitQcDate": "2022-12-05",
            "studyFirstPostDateStruct": {
                "date": "2022-12-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-20",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Vanda Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment."
        },
        "conditionsModule": {
            "conditions": [
                "Schizophrenia",
                "Bipolar I Disorder"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Iloperidone",
                    "type": "EXPERIMENTAL",
                    "description": "Open-label iloperidone",
                    "interventionNames": [
                        "Drug: Iloperidone"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Iloperidone",
                    "description": "oral tablet",
                    "armGroupLabels": [
                        "Iloperidone"
                    ],
                    "otherNames": [
                        "VYV-683",
                        "FANAPT"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of participants with treatment-emergent adverse events (TEAEs) in the treatment period.",
                    "timeFrame": "1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient is willing and able to provide assent and willing to complete all aspects of the study\n* Patient's parent or legal guardian willing and able to provide consent\n* Male or female patients 12 through 17 years of age (inclusive)\n* Clinical diagnosis of either schizophrenia or bipolar I disorder\n\nExclusion Criteria:\n\n* Use of other investigational drugs at the time of enrollment, or within 30 days or 5 half-lives of enrollment, whichever is longer\n* A positive test for drugs of abuse",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "12 Years",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Vanda Pharmaceuticals Inc.",
                    "role": "CONTACT",
                    "phone": "202-734-3400",
                    "email": "clinicaltrials@vandapharma.com"
                }
            ],
            "locations": [
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33173",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "W. Miami",
                    "state": "Florida",
                    "zip": "33144",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.76343,
                        "lon": -80.29616
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30318",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30331",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "Decatur",
                    "state": "Georgia",
                    "zip": "30030",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.77483,
                        "lon": -84.29631
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63128",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45221",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vanda Pharmaceuticals",
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "Garfield Heights",
                    "state": "Ohio",
                    "zip": "44125",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.417,
                        "lon": -81.60596
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Westlake",
                    "state": "Ohio",
                    "zip": "44145",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.45532,
                        "lon": -81.91792
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "DeSoto",
                    "state": "Texas",
                    "zip": "75115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vanda Pharmaceuticals Inc.",
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.58986,
                        "lon": -96.85695
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "Everett",
                    "state": "Washington",
                    "zip": "98201",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.97898,
                        "lon": -122.20208
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012559",
                    "term": "Schizophrenia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019967",
                    "term": "Schizophrenia Spectrum and Other Psychotic Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M15376",
                    "name": "Schizophrenia",
                    "asFound": "Schizophrenia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21838",
                    "name": "Schizophrenia Spectrum and Other Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000081732",
                    "term": "Iloperidone"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014150",
                    "term": "Antipsychotic Agents"
                },
                {
                    "id": "D000014149",
                    "term": "Tranquilizing Agents"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M259754",
                    "name": "Iloperidone",
                    "asFound": "Cable",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16904",
                    "name": "Antipsychotic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}